- Home
- WNS vs SLNO Comparison
WNS vs SLNO Comparison
Compare WNS & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNS
- SLNO
- Stock Information
- Founded
- WNS 1996
- SLNO 1999
- Country
- WNS India
- SLNO United States
- Employees
- WNS N/A
- SLNO N/A
- Industry
- WNS Business Services
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WNS Consumer Discretionary
- SLNO Health Care
- Exchange
- WNS Nasdaq
- SLNO Nasdaq
- Market Cap
- WNS 3.2B
- SLNO 3.8B
- IPO Year
- WNS N/A
- SLNO 2014
- Fundamental
- Price
- WNS $75.70
- SLNO $51.17
- Analyst Decision
- WNS Hold
- SLNO Strong Buy
- Analyst Count
- WNS 9
- SLNO 10
- Target Price
- WNS $67.67
- SLNO $112.50
- AVG Volume (30 Days)
- WNS 593.3K
- SLNO 1.7M
- Earning Date
- WNS 10-16-2025
- SLNO 11-05-2025
- Dividend Yield
- WNS N/A
- SLNO N/A
- EPS Growth
- WNS 21.19
- SLNO N/A
- EPS
- WNS 3.60
- SLNO N/A
- Revenue
- WNS $1,345,621,000.00
- SLNO $32,656,999.00
- Revenue This Year
- WNS $7.23
- SLNO N/A
- Revenue Next Year
- WNS $9.29
- SLNO $175.39
- P/E Ratio
- WNS $21.03
- SLNO N/A
- Revenue Growth
- WNS 1.94
- SLNO N/A
- 52 Week Low
- WNS $42.62
- SLNO $41.50
- 52 Week High
- WNS $75.84
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- WNS 72.01
- SLNO 23.27
- Support Level
- WNS $75.39
- SLNO $50.63
- Resistance Level
- WNS $75.84
- SLNO $72.99
- Average True Range (ATR)
- WNS 0.16
- SLNO 4.38
- MACD
- WNS -0.13
- SLNO -1.38
- Stochastic Oscillator
- WNS 73.08
- SLNO 2.42
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically, the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), South Africa, and other countries.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.